Drug Trial Radar · NCT06311721
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
315
Actual
Start
Sep 9, 2024
Primary completion
Jan 10, 2028
Study completion Apr 24, 2028
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this trial is to demonstrate pharmacokinetic (PK) similarity of ABP 234 compared with the pembrolizumab reference product (Keytruda®).
Conditions
- Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Interventions
ABP 234Drug
Intravenous administration
Pembrolizumab (US)Drug
Intravenous administration
Pembrolizumab (EU)Drug
Intravenous administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the serum concentration-time curve (AUC) from time 0 to 21 days (AUC21d) of ABP 234Time frame: 21 days
- AUC21d of pembrolizumab (US)Time frame: 21 days
- AUC21d of pembrolizumab (EU)Time frame: 21 days
- AUC at steady state between Week 16 and Week 19 (AUCtau_ss) of ABP 234Time frame: Week 16 through Week 19
- AUCtau_ss of pembrolizumab (US)Time frame: Week 16 through Week 19
- AUCtau_ss of pembrolizumab (EU)Time frame: Week 16 through Week 19
Locations
218 sites in 23 countries. Site status is shown where the registry gives one.
Precision NextGen Oncology and Research Center
Beverly Hills, California
TOI Clinical Research
Cerritos, California
Cancer and Blood Specialty Clinic (CBSC)
Los Alamitos, California
Valkyrie Clinical Trials
Los Angeles, California
PIH Health Hospital
Whittier, California
Millennium Oncology - Hollywood
Hollywood, Florida
BRCR Medical Center Inc.
Tamarac, Florida
Accellacare Duly
Plainfield, Illinois
Accellacare of McFarland
Ames, Iowa
Detroit Clinical Research Center, PC
Farmington Hills, Michigan
North Shore Hematology-Oncology Associates P.C. d/b/a New York Cancer & Blood Specialists
Shirley, New York
Gabrail Cancer Center Research
Canton, Ohio
Millennium Research and Clinical Development, LLC
Houston, Texas
Texas Oncology, P.A
San Antonio, Texas
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Wytheville, Virginia
IONC - Instituto Oncologico de Cordoba
Córdoba, Argentina
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
Centro de Investigacion Pergamino SA
Pergamino, Buenos Aires, Argentina
Fundacion ARS Medica
San Salvador de Jujuy, Jujuy Province, Argentina
Sanatorio Britanico De Rosario
Rosario, Santa Fe Province, Argentina
Hospital Provincial del Centenario
Rosario, Santa Fe Province, Argentina
Klinikum Klagenfurt am Woerthersee
Klagenfurt, Austria
Ordensklinikum Linz GmbH Elisabethinen
Linz, Austria
Hospital Nossa Senhora das Gracas
Canoas, Brazil
CIONC - Centro Integrado de Oncologia de Curitiba
Curitiba, Brazil
Centro Integrado de Pesquisa em Oncologia - Hospital Nossa Senhora da Conceio
Porto Alegre, Brazil
Instituto Nacional de Cancer (INCA)
Rio de Janeiro, Brazil
Instituto Americas - Ensino, Pesquisa e Inovacao
Rio de Janeiro, Brazil
Oncoclinicas Rio de Janeiro S.A (Centro de Tratamento de Tumores Botafogo)
Rio de Janeiro - RJ, Brazil
Instituto D'Or de Pesquisa e Ensino - Hospital Sao Rafael
Salvador, Brazil
Hospital Alemao Oswaldo Cruz (HAOC)
São Paulo, Brazil
Instituto Brasileiro de Controle do Cancer - IBCC Oncologia
São Paulo, Brazil
CRIO - Centro Regional Integrado de Oncologia
Fortaleza, Ceará, Brazil
OC Oncoclinicas Oncovida
Brasília, Destrito Federal, Brazil
Centro de Pesquisas Clinicas em Oncologia (CPCO)/HECI
Cachoeiro de Itapemirim, Espírito Santo, Brazil
Associacao Feminina de Educacao e Combate ao Cancer(AFECC) - Hospital Santa Rita
Vitória, Espírito Santo, Brazil
Hospital Santa Izabel, Santa Casa de Misericordia da Bahia
Salvador, Estado de Bahia, Brazil
Cetus Oncologia S.A. Unidade Belo Horizonte
Belo Horizonte, Minas Gerais, Brazil
Nucleo de Ensino Pesquisa e Inovacao Mario Penna
Belo Horizonte, Minas Gerais, Brazil
Fundacao Sao Francisco Xavier - Hospital Marcio Cunha (HMC) - Unidade I
Ipatinga, Minas Gerais, Brazil
Showing 40 of 218 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.